Antioxidative protection in hypertensive patients treated with diuretics

American Journal of Hypertension

Volumn 18, Issue 8, 2005, Pages 1130-1132

  Skalska, Anna ^a   Ga̧sowski, Jerzy ^a   Stȩpniewski, Marek ^a   Grodzicki, Tomasz ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Antioxidative protection; Diuretics; Hypertension

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FERRIC ION; THIAZIDE DIURETIC AGENT; URIC ACID;

AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; FEMALE; HUMAN; HYPERTENSION; MALE; MULTIPLE REGRESSION; OXIDATION; PLASMA; PRIORITY JOURNAL; SMOKING;

ADRENERGIC BETA-ANTAGONISTS; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIOXIDANTS; DIURETICS; FEMALE; FERRIC COMPOUNDS; FERROUS COMPOUNDS; HUMANS; HYPERTENSION; MALE; OXIDATION-REDUCTION; SODIUM CHLORIDE SYMPORTER INHIBITORS;

EID: 23744510008     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjhyper.2005.03.731     Document Type: Article

References (11)

1. Guidelines Committee 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension J Hypertens 21 2003 1011 1053
2. A.V. Chobanian, G.L. Bakris, H.R. Black, W.C. Cushman, A.G. Lee, J.L. Izzo, D.W. Jones, B.J. Materson, S. Oparil, J.T.J. Wright, E.J. Rocella National High Blood Pressure Education Program Coordinating Committee The Seventh Report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. The JNC 7 report JAMA 289 2003 2560 2572
3. J.A. Staessen, J.-G. Wang, W.H. Birkenhager Outcome beyond blood pressure control? Eur Heart J 24 2003 504 514
4. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) JAMA 283 2000 1967 1975
5. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group Major outcomes in high-risk hypertensive patients randomised to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic. The Antihypertensive and lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) JAMA 288 2002 2981 2997
6. L.V. Franse, M. Pahor, M. Di Bari, G.W. Somes, W.C. Cushman, W.B. Applegate Hypokalemia associated with diuretic use and cardiovascular events in the Systolic Hypertension in the Elderly Program Hypertension 35 2000 1025 1030
7. J. Redon, M.R. Oliva, C. Tormos, V. Giner, J. Chaves, A. Iradi, G.T. Saez Antioxidant activities and oxydative stress byproducts in human hypertension Hypertension 41 2003 1096 1101
8. Y. Uehara, Y. Kawabata, H. Shirahase, K. Wada, Y. Hashizume, S. Morishita, A. Numabe, J. Iwai Oxygen radical scavengers and renal protection by indapamide diuretic in salt-induced hypertension of Dahl strain rats J Cardiovasc Pharmacol 22 Suppl 6 1993 S42 S46
9. I.F.F. Benzie, J.J. Strain The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power" the FRAP assay Analytical Biochem 239 1996 70 76
10. A. Fournier, F.H. Messerli, J.M. Achard, L. Fernande Cerebroprotection mediated by angiotensin II. A hypothesis supported by recent randomized clinical trials J Am Coll Cardiol 43 2004 1343 1447
11. G.T. Saez, C. Tormos, V. Giner, J. Chaves, J.V. Lozano, A. Iradi, J. Redon Factors related to the impact of antihypertensive treatment in antioxidant activities and oxidative stress by-products in human hypertension Am J Hypertens 17 2004 809 816